Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6

Fig. 6

MSCs-Exo treatment altered the proportion of Th2 cells and Th17 cells in MLN of colitis mice. a Flow cytometry analysis showing the proportion of CD4+ IL-4+ (Th2) T cells in mesenteric lymph nodes (MLN) and spleen. The histogram represented the percentage of Th2 cells. b Percentage of cells expressing CD4+ IL-17+ (Th17) T cells from MLN and spleen. The histogram represented the percentage of Th17 cells. n = 4–5 per group, data are presented as mean ± SD. *P < 0.05 and ns indicates P > 0.05

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512